Earlier this month, the U.S. Food and Drug Administration (“FDA”) issued a draft guidance, “Key Information and Facilitating Understanding in Informed Consent”, with notable implications for clinical ...

the beneficiary is outside the United States and does not have a valid H‑1B visa; or the petition requests or is approved for consular notification. Notably, the fee does not apply to petitions that ...